An analyst from Oppenheimer maintained Achieve Life Sciences (NASDAQ: ACHV) at 'outperform' with a price target of $21.000 from a prior price target of %currency%%price%. Prior to this...
Achieve Life Sciences (NASDAQ:ACHV) has reported significant advancements in the development of cytisinicline, a novel treatment for nicotine dependence, during its recent earnings call. The...
Investing.com - Achieve Life Sciences (NASDAQ: ACHV) reported third quarter EPS of $-0.340, $0.03 better than the analyst estimate of $-0.370. Revenue for the quarter came in at $0.00 versus...
Investing.com - Achieve Life Sciences (NASDAQ: ACHV) reported second quarter EPS of $-0.430, $0.02 worse than the analyst estimate of $-0.410. Revenue for the quarter came in at $0.00 versus...
Achieve Life Sciences, Inc. (NASDAQ:ACHV), today announced the publication in JAMA of the results from the Phase 3 ORCA-2 randomized placebo-controlled clinical trial of cytisinicline as a...
An analyst from Lake Street Capital Markets maintained Achieve Life Sciences (NASDAQ: ACHV) at 'buy' with a price target of $19.00 from a prior price target of %currency%%price%. Prior to...
Achieve Life Sciences, Inc. (Nasdaq: NASDAQ:ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and...
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
Investing.com - Achieve Life Sciences (NASDAQ: ACHV) reported first quarter EPS of $-0.500, $0.28 better than the analyst estimate of $-0.780. Revenue for the quarter came in at $0.00 versus...
Achieve Life Sciences, Inc. (Nasdaq: NASDAQ:ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and...
Achieve Life Sciences, Inc. (Nasdaq: NASDAQ:ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and...
Achieve Life Sciences, Inc. (Nasdaq: NASDAQ:ACHV) today announced that the last study follow-up visit for the last subject enrolled in the Phase 3 ORCA-3 trial has occurred.“We are pleased...
Investing.com - Achieve Life Sciences (NASDAQ: ACHV) reported first quarter EPS of $-0.830, $0.21 better than the analyst estimate of $-1.040. Revenue for the quarter came in at $0.00 versus...
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and...
Investing.com - Achieve Life Sciences reported on Monday third quarter {{erl-16799||earnings that missed analysts' forecasts and revenue that fell short of expectations. Achieve Life...
Achieve Life Sciences (ACHV) reported Q3 EPS of ($1.35), $0.22 worse than the analyst estimate of ($1.13).
Achieve Life Sciences (NASDAQ:ACHV) reported Q2 EPS of ($1.08), $0.27 worse than the analyst estimate of ($0.81).
Achieve Life Sciences (NASDAQ:ACHV) reported Q1 EPS of ($0.80), $0.01 better than the analyst estimate of ($0.81).
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Telecoms and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Utilities, Technology and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Oil & Gas, Basic Materials and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Utilities, Consumer Services and Telecoms sectors propelled shares higher while losses in the Financials,...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Telecoms, Basic Materials and Financials sectors propelled shares higher while losses in the Technology,...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Industrials, Technology and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Industrials, Oil & Gas and Utilities sectors propelled shares higher while losses in the Healthcare,...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Telecoms, Utilities and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
